Company Performance Metrics
- Tetsuji Raizan: Executive chairman
- Tanaka Jun: President / CEO
Amnos is engages in developing, manufacturing and selling dried human amnion. The company aims to commercialize "Hyper Dry Amnion". The company is trying to use it for medical equipment and regenerative medicine by drying the amniotic membrane. The amniotic membrane refers to the thin membrane that wraps the baby in the womb of the
pregnant woman. The amniotic membrane has received attention because it has the ability to activate cells against wounds, burns, and surgical damage. However, since it was very difficult to preserve, it has been discarded until now. The company's amnion drying technology has found a way to effectively utilize amnion that has not been used before. Since the amniotic membrane was a discarded part, ethical problems have already been solved. There is almost no rejection due to differences in blood type, gender, race, etc., and safety is high. In the future, the company aims to introduce it into medical devices in the ophthalmic area and wound covering area.